Upgrade to SI Premium - Free Trial

Novan (NOVN)

0.09 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/13/23 *Est.)

Latest Headlines

Form 6-K NOVARTIS AG For: Nov 28 November 28, 2023 6:19 AM - SEC Filing Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization November 24, 2023 10:00 AM - PR NewsWire Form 6-K NOVARTIS AG For: Oct 30 October 30, 2023 6:05 AM - SEC Filing Form 6-K NOVARTIS AG For: Sep 30 October 24, 2023 6:34 AM - SEC Filing FDA approves Novartis Cosentyx® as first intravenous (IV) formulation interleukin-17A antagonist for rheumatic diseases October 6, 2023 4:20 PM - PR NewsWire Form 6-K NOVARTIS AG For: Oct 04 October 4, 2023 6:57 AM - SEC Filing Form 6-K NOVARTIS AG For: Oct 02 October 2, 2023 6:09 AM - SEC Filing Form 144 NOVARTIS AG Filed by: Kowalski Robert William September 19, 2023 4:09 PM - SEC Filing Novartis (NVS) Issues Voluntary Nationwide Recall of One Lot of Sandimmune Oral Solution, 100 mg/mL due to Crystallization September 11, 2023 10:01 AM - StreetInsider Novartis Issues Voluntary Nationwide Recall of One Lot of Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization September 11, 2023 10:00 AM - PR NewsWire Form 25-NSE Novan, Inc. Filed by: Nasdaq Stock Market LLC September 8, 2023 10:13 AM - SEC Filing Form 8-K Novan, Inc. For: Aug 31 September 7, 2023 4:59 PM - SEC Filing Form 6-K NOVARTIS AG For: Sep 05 September 5, 2023 6:10 AM - SEC Filing Full Article List